Cargando…
Absorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) Study in Patients With Cystic Fibrosis Receiving Enteral Feeding
OBJECTIVES: Pancreatic insufficiency (PI) and malabsorption of fats lead to reduced caloric intake, inability to maintain weight, and increased gastrointestinal symptoms. Thus, enteral nutrition (EN) is used in patients with cystic fibrosis (CF) and poor nutritional status. The current study evaluat...
Autores principales: | Stevens, John, Wyatt, Colby, Brown, Perry, Patel, Dhiren, Grujic, Danica, Freedman, Steven D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155360/ https://www.ncbi.nlm.nih.gov/pubmed/30074573 http://dx.doi.org/10.1097/MPG.0000000000002110 |
Ejemplares similares
-
Fat digestion using RELiZORB in children with short bowel syndrome who are dependent on parenteral nutrition: Protocol for a 90-day, phase 3, open labeled study
por: Tsikis, Savas T., et al.
Publicado: (2023) -
Relationship of Initial Pancreatic Enzyme Replacement Therapy Dose With Weight Gain in Infants With Cystic Fibrosis
por: Schechter, Michael S., et al.
Publicado: (2018) -
Epidemiology of Pediatric Acute Pancreatitis in Taiwan: A Nationwide Population-based Study
por: Cheng, Yu-Jyun, et al.
Publicado: (2019) -
A conformationally adaptive macrocycle: conformational complexity and host–guest chemistry of zorb[4]arene
por: Yang, Liu-Pan, et al.
Publicado: (2018) -
Effect of BioZorb® surgical marker placement on post-operative radiation boost target volume
por: Wiens, Naomi, et al.
Publicado: (2018)